| Keywords: |
leukemia; cancer recurrence; cisplatin; cancer adjuvant therapy; cancer patient; cancer staging; recurrence risk; follow up; cancer incidence; lymph node dissection; letter; carboplatin; computer assisted tomography; neoplasm recurrence, local; etoposide; pathology; risk factor; infertility; cardiovascular disease; tumor recurrence; testicular neoplasms; bleomycin; clinical decision making; neoplasms, germ cell and embryonal; orchiectomy; germ cell tumor; seminoma; retrograde ejaculation; social psychology; oncologist; humans; human; male; priority journal
|
